Ledger.Open graph →
SEC Form D · filed December 8, 2023

Deka Biosciences, Inc

Offering
$41.4M
Sold
$29.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GERMANTOWN, MD
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

John Mumm · Germantown, MDExec · DirectorPavel Khrimian · Germantown, MDExecLu Han · Germantown, MDDirectorRakhshita Dhar · Germantown, MDDirectorPeter Buzy · Germantown, MDDirectorValueWorks LLC · New York, NYExec · DirectorJean-Christophe R. Ehlinger · Senningerberg, LuxembourgExecGeoffrey L. Butler · New York, NYDirectorDetlev Biniszkiewicz · Cambridge, MADirectorChristopher Yaen · Germantown, MDExecPeter S. Feinberg · New York, NYExec · DirectorZachary Winner · Dover, DEExecLorcan Murphy · DUBLIN 2, IrelandDirectorDetlev Biniszkiewicz · Cambridge, MADirectorChristopher Yaen · Germantown, MDExecRakhshita Dhar · Germantown, MDDirectorPeter Buzy · Germantown, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗